DRKS

DRKS, short for Deutsches Register Klinischer Studien, is a public CLInical trial registry mAIntained for Germany. It hosts structured records of clinical studies, letting researchers, clinicians, patients, and journalists look up trials by topic, condition, sponsor, or recruitment status. The registry functions as a research data resource rather than a Generative AI product, and it is commonly used as a reference point when assessing study transparency.

What it does

The service provIDEs a searchable Database of registered clinical trials. Each record typically includes the study title, objectives, design, inclusion and exclusion criteria, participating sites, recruitment status, and contACT details. Users can browse the registry or query it to locate trials relevant to a specific disease area or intervention. Because registry entries are intended to be public, DRKS supports transparency about which studies exist and how they are structured.

Key capabilities

• Search and browse registered clinical studies across medical fields.
• Access structured summaries covering study design, eligibility, and status.
• Identify trial sites and contact points for further inquiry.
• Support transparency and reporting checks for research and review work.
• Public web access without account requirements for bASIc search.

Who it is for

DRKS is useful for clinical researchers, ethics reviewers, systematic review authors, healthcare Professionals, patient advocacy groups, and members of the public who want to learn about ongoing or completed studies. Journalists and policy analysts may also consult registry entries when verifying claims about clinical research activity in Germany.

How to get started

Visit the registry through a web browser and use the search interface to enter a condition, intervention, sponsor, or study identifier. Results list matching records, and each entry opens into a structured detail page. Refining queries with specific terms usually produces more focused results, and users should note that record completeness and update frequency may vary by study sponsor.

Pricing and access caveat

Basic access to the registry APPears to be free of charge. Availability, interface language options, and record detail may change over time, and some studies may be registered in other registries instead. Users should verify current terms directly with the registry and treat indiVidual entries as sponsor-provided Information rather than independently validated findings.